Skip to main content

Table 3 Univariate regression models of TP, albumin, LDH, CRP, ESR, NLR, PLR, B-symptomatology, “bulky” tumor mass, mediastinal involvement by tumor mass and ECOG PS

From: Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients

Variable

p

OR

95% CI for OR

TP

0.026

1.91

1.08–3.39

Albumin

0.036

2.16

1.05–4.46

LDH

0.001

2.368

1.404–3.995

CRP

0.008

2.75

1.29–5.84

ESR

0.18

1.76

0.78–4.02

NLR

0.001

2.5

1.48–4.21

PLR

0.003

2.24

1.31–3.83

B-symptomatology

0.001

2.64

1.49–4.67

“Bulky” tumor mass

0.001

2.43

1.47–4.01

Mediastinal involvement

0.005

2.05

1.24–3.39

ECOG PS

0.015

1.99

1.14–3.5

  1. Legend: OR odds ratio, CI confidence interval, TP total proteins, LDH lactate dehydrogenase, CRP C-reactive protein, ESR erythrocyte sedimentation rate, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, ECOG PS Eastern Oncology Cooperative Group Performance Status